The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
The global Point-of-Care Diagnostics market size is expected to reach US$ 35370 million by 2029, growing at a CAGR of 5.7% from 2023 to 2029. The market is mainly driven by the significant applications of Point-of-Care Diagnostics in various end use industries. The expanding demands from the Home, Hospitals and Ambulatory Care,, are propelling Point-of-Care Diagnostics market. Glucose Monitoring Kits, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Infectious Diseases Testing Kits segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Point-of-Care Diagnostics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Point-of-Care Diagnostics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Point-of-Care Diagnostics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Point-of-Care Diagnostics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Point-of-Care Diagnostics covered in this report include Abaxis, Abbott, Bayer, Danaher Corporation, Becton Dickinson, Johnson & Johnson, Nipro, Roche Diagnostics and Siemens, etc.
The global Point-of-Care Diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
- Abaxis
- Abbott
- Bayer
- Danaher Corporation
- Becton Dickinson
- Johnson & Johnson
- Nipro
- Roche Diagnostics
- Siemens
- Samsung Medison
Global Point-of-Care Diagnostics market, by region:
- North America (U.S., Canada, Mexico)
- Europe (Germany, France, UK, Italy, etc.)
- Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
- South America (Brazil, etc.)
- Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Point-of-Care Diagnostics market, Segment by Type:
- Glucose Monitoring Kits
- Infectious Diseases Testing Kits
- Cardiometabolic Monitoring Kits
- Coagulation Monitoring Kits
- Hematology Testing Kits
- Urinalysis Testing Kits
- Cholesterol Test Strips
- Drugs-Of-Abuse Testing Kits
- Tumor/Cancer Markers
- Other
Global Point-of-Care Diagnostics market, by Application
- Home
- Hospitals
- Ambulatory Care
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Point-of-Care Diagnostics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index
1 Market Overview of Point-of-Care Diagnostics
1.1 Point-of-Care Diagnostics Market Overview
1.1.1 Point-of-Care Diagnostics Product Scope
1.1.2 Point-of-Care Diagnostics Market Status and Outlook
1.2 Global Point-of-Care Diagnostics Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Point-of-Care Diagnostics Market Size by Region (2018-2029)
1.4 Global Point-of-Care Diagnostics Historic Market Size by Region (2018-2023)
1.5 Global Point-of-Care Diagnostics Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Point-of-Care Diagnostics Market Size (2018-2029)
1.6.1 North America Point-of-Care Diagnostics Market Size (2018-2029)
1.6.2 Europe Point-of-Care Diagnostics Market Size (2018-2029)
1.6.3 Asia-Pacific Point-of-Care Diagnostics Market Size (2018-2029)
1.6.4 Latin America Point-of-Care Diagnostics Market Size (2018-2029)
1.6.5 Middle East & Africa Point-of-Care Diagnostics Market Size (2018-2029)
2 Point-of-Care Diagnostics Market by Type
2.1 Introduction
2.1.1 Glucose Monitoring Kits
2.1.2 Infectious Diseases Testing Kits
2.1.3 Cardiometabolic Monitoring Kits
2.1.4 Coagulation Monitoring Kits
2.1.5 Hematology Testing Kits
2.1.6 Urinalysis Testing Kits
2.1.7 Cholesterol Test Strips
2.1.8 Drugs-Of-Abuse Testing Kits
2.1.9 Tumor/Cancer Markers
2.1.10 Other
2.2 Global Point-of-Care Diagnostics Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Point-of-Care Diagnostics Historic Market Size by Type (2018-2023)
2.2.2 Global Point-of-Care Diagnostics Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Point-of-Care Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Point-of-Care Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Point-of-Care Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Point-of-Care Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Point-of-Care Diagnostics Revenue Breakdown by Type (2018-2029)
3 Point-of-Care Diagnostics Market Overview by Application
3.1 Introduction
3.1.1 Home
3.1.2 Hospitals
3.1.3 Ambulatory Care
3.2 Global Point-of-Care Diagnostics Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Point-of-Care Diagnostics Historic Market Size by Application (2018-2023)
3.2.2 Global Point-of-Care Diagnostics Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Point-of-Care Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Point-of-Care Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Point-of-Care Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Point-of-Care Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Point-of-Care Diagnostics Revenue Breakdown by Application (2018-2029)
4 Point-of-Care Diagnostics Competition Analysis by Players
4.1 Global Point-of-Care Diagnostics Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Point-of-Care Diagnostics as of 2022)
4.3 Date of Key Players Enter into Point-of-Care Diagnostics Market
4.4 Global Top Players Point-of-Care Diagnostics Headquarters and Area Served
4.5 Key Players Point-of-Care Diagnostics Product Solution and Service
4.6 Competitive Status
4.6.1 Point-of-Care Diagnostics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Abaxis
5.1.1 Abaxis Profile
5.1.2 Abaxis Main Business
5.1.3 Abaxis Point-of-Care Diagnostics Products, Services and Solutions
5.1.4 Abaxis Point-of-Care Diagnostics Revenue (US$ Million) & (2018-2023)
5.1.5 Abaxis Recent Developments
5.2 Abbott
5.2.1 Abbott Profile
5.2.2 Abbott Main Business
5.2.3 Abbott Point-of-Care Diagnostics Products, Services and Solutions
5.2.4 Abbott Point-of-Care Diagnostics Revenue (US$ Million) & (2018-2023)
5.2.5 Abbott Recent Developments
5.3 Bayer
5.3.1 Bayer Profile
5.3.2 Bayer Main Business
5.3.3 Bayer Point-of-Care Diagnostics Products, Services and Solutions
5.3.4 Bayer Point-of-Care Diagnostics Revenue (US$ Million) & (2018-2023)
5.3.5 Danaher Corporation Recent Developments
5.4 Danaher Corporation
5.4.1 Danaher Corporation Profile
5.4.2 Danaher Corporation Main Business
5.4.3 Danaher Corporation Point-of-Care Diagnostics Products, Services and Solutions
5.4.4 Danaher Corporation Point-of-Care Diagnostics Revenue (US$ Million) & (2018-2023)
5.4.5 Danaher Corporation Recent Developments
5.5 Becton Dickinson
5.5.1 Becton Dickinson Profile
5.5.2 Becton Dickinson Main Business
5.5.3 Becton Dickinson Point-of-Care Diagnostics Products, Services and Solutions
5.5.4 Becton Dickinson Point-of-Care Diagnostics Revenue (US$ Million) & (2018-2023)
5.5.5 Becton Dickinson Recent Developments
5.6 Johnson & Johnson
5.6.1 Johnson & Johnson Profile
5.6.2 Johnson & Johnson Main Business
5.6.3 Johnson & Johnson Point-of-Care Diagnostics Products, Services and Solutions
5.6.4 Johnson & Johnson Point-of-Care Diagnostics Revenue (US$ Million) & (2018-2023)
5.6.5 Johnson & Johnson Recent Developments
5.7 Nipro
5.7.1 Nipro Profile
5.7.2 Nipro Main Business
5.7.3 Nipro Point-of-Care Diagnostics Products, Services and Solutions
5.7.4 Nipro Point-of-Care Diagnostics Revenue (US$ Million) & (2018-2023)
5.7.5 Nipro Recent Developments
5.8 Roche Diagnostics
5.8.1 Roche Diagnostics Profile
5.8.2 Roche Diagnostics Main Business
5.8.3 Roche Diagnostics Point-of-Care Diagnostics Products, Services and Solutions
5.8.4 Roche Diagnostics Point-of-Care Diagnostics Revenue (US$ Million) & (2018-2023)
5.8.5 Roche Diagnostics Recent Developments
5.9 Siemens
5.9.1 Siemens Profile
5.9.2 Siemens Main Business
5.9.3 Siemens Point-of-Care Diagnostics Products, Services and Solutions
5.9.4 Siemens Point-of-Care Diagnostics Revenue (US$ Million) & (2018-2023)
5.9.5 Siemens Recent Developments
5.10 Samsung Medison
5.10.1 Samsung Medison Profile
5.10.2 Samsung Medison Main Business
5.10.3 Samsung Medison Point-of-Care Diagnostics Products, Services and Solutions
5.10.4 Samsung Medison Point-of-Care Diagnostics Revenue (US$ Million) & (2018-2023)
5.10.5 Samsung Medison Recent Developments
6 North America
6.1 North America Point-of-Care Diagnostics Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Point-of-Care Diagnostics Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Point-of-Care Diagnostics Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Point-of-Care Diagnostics Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Point-of-Care Diagnostics Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Point-of-Care Diagnostics Market Dynamics
11.1 Point-of-Care Diagnostics Industry Trends
11.2 Point-of-Care Diagnostics Market Drivers
11.3 Point-of-Care Diagnostics Market Challenges
11.4 Point-of-Care Diagnostics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
